Vikram Lamba is listed as an executive officer and director on 12 SEC Form D filings by 6 issuers between Jan 2010 and Jun 2026. Largest by amount reported sold: Magnus Medical, Inc. (Burlingame, CA — biotechnology — 2025; $49M reported sold to 10 investors), Zosano Pharma Inc (Fremont, CA — pharmaceuticals — 2011; $39M reported sold to 6 investors), PREDICTIVE BIOSCIENCES, INC (Lexington, MA — biotechnology — 2010; $25.4M reported sold to 10 investors), Zosano Pharma Corp (Fremont, CA — pharmaceuticals — 2013–2015; $15M reported sold to 18 investors), Anodyne Nanotech, Inc. (Boston, MA — other health care — 2026; $12.6M reported sold to 47 investors) and 1 more (all listed below).
What this means A repeat sponsor — 6 separate companies raised money with this person listed as executive officer and director, over about 16 years. Across those companies the filings report $141.4M sold in total.
3 of the issuers belong to the sponsor group Zosano Pharma (3 issuers, $12.6M reported sold, 2010–2016).
What this means A sponsor group is one team that sets up a new company for each deal. Zosano Pharma has 3 companies on file and $12.6M reported sold in total — the group page shows the whole track record in one place.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 2 court cases matching the name, 1 bankruptcy case matching the name listed in Key records below.
What this means 3 records came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 12 public filings for Vikram Lamba and found 6 differences, 1 worth asking the sponsor about: Vikram Lamba is no longer listed on the May 26, 2026 amendment; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.